Clinical Trials Logo

Clinical Trial Summary

Study aims to verify the hypothesis: - N-acetylcysteine (NAC) supplementation improves exercise capacity in people training endurance sports and the effectiveness of this supplementation depends on the polymorphism of genes related to folate and glutathione metabolism. - NAC supplementation affects the parameters of oxidative stress among women and men training endurance disciplines


Clinical Trial Description

- Glutathione depletion caused by a combination of intense physical exertion associated with the generation of significant amounts of reactive oxygen species (ROS), and possibly with having an unfavorable variant of the methylenetetrahydrofolate reductase (MTHFR), glutamate-cysteine ligase catalytic subunit (GCLC); glutamate-cysteine ligase modifier subunit (GCLM); glutathione S-transferase Pi 1 (GSTP1); glutathione synthetase (GSS) or cystathionine-β-synthase (CBS) genes may contribute to lower adaptation to exercise, but also to deterioration of health of people training endurance sports. - The main objective of the study is to verify the hypothesis that NAC supplementation has a beneficial effect on regeneration between intense exercise tests simulating a race characteristic for a given discipline. In addition, this study is aimed at checking whether genotype may modify the effectiveness of the supplementation measured as exercise and biochemical parameters . A double-blind study involving 100 women and men supplementing 1200 mg of N-acetylcysteine daily or 1200 mg of maltodextrin in three equal doses. Supplementation will last for 7 days. Blood sampling and body composition testing will be performed in the morning of the exercise test day. Discipline-specific exercise testing will be performed before and after the intervention. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05604586
Study type Interventional
Source Poznan University of Life Sciences
Contact Agata Chmurzynska, Professor
Phone 61 8466181
Email agata.chmurzynska@up.poznan.pl
Status Recruiting
Phase N/A
Start date May 1, 2022
Completion date December 31, 2025

See also
  Status Clinical Trial Phase
Completed NCT04934709 - Photobiomodulation Therapy Combined With Static Magnetic Field on the Subsequent Performance N/A
Completed NCT02816411 - Protein Supplementation and Skeletal Muscle Healing Process N/A
Completed NCT01778309 - NAC Supplementation and Skeletal Muscle Performance N/A
Completed NCT04523675 - NAC Supplementation and Soccer Specific Performance N/A